Stock Market

DatChat (NASDAQ:DATS) is a private messaging application company with little going for it — aside from the cash it raised at its Aug. 13 initial public offering (IPO). DatChat raised $11.04 million according to its most recent prospectus. Somehow, DATS stock now has a market value of about $220 million, according to Yahoo! Finance. Source:

Despite some positive news, it’s difficult to see why investors should direct their capital toward Carnival (NYSE:CCL) stock at current levels. CCL stock is down more than 14% in the last six months. The company has seen some encouraging signs regarding its business operations, but the overall picture remains negative. Further, as the pandemic wears

FuelCell Energy (NASDAQ:FCEL) saw its shares close at a high of $27.96 in early February. Since then, the story has been much less impressive, with the stock in a long slide. At this point, FCEL stock is trading for $6.71, down 76% from its February high. Shares are also down 40% for the year. So,

As I put it in late August, Palantir Technologies (NYSE:PLTR) stock seemed to be a situation where it would continue to stay strong performance-wise, that is, until markets get volatile. Now? Said volatility has started to play out. Shares in this hot big data play have slid back in price. With this, what’s next for PLTR

The Walt Disney Company (NYSE:DIS) used to pay a consistent dividend and also buy back its own shares. However, for the past year and a half, since the end of 2019, it stopped returning capital to its shareholders. It’s now clear that DIS stock has not done very well as a result of this decision.

Globalstar (NYSEAMERICAN:GSAT) has been on a roller coaster ride so far in 2021. GSAT stock, a satellite communications and internet-of-things (IoT) play, zoomed from 34 cents to just over $2.50 per share during February’s “meme stock” mania. Source: NicoElNino / Shutterstock.com Then, in the spring — as this trend cooled — shares dipped back to around

Believe it or not, the hottest hypergrowth industry in the world right now is one that not many folks on Wall Street are chatting about, and that’s the Buy Now, Pay Later market. Source: Shutterstock Buy Now, Pay Later – or BNPL – is a relatively new type of digital fintech product that allows folks

Joby Aviation (NASDAQ:JOBY) stock is down 31% since emerging from a SPAC deal with Reinvent Technology Partners on Aug. 11. That makes sense, because Joby is a “pre-revenue” company. Investors have nothing to judge JOBY stock by except plans, sponsors and a prototype. Source: T. Schneider / Shutterstock.com The company intends to deliver an electric

Editor’s note: This column is part of InvestorPlace.com’s Best Stocks for 2021 contest. Louis Navellier’s pick for the contest is Fiverr International (NYSE:FVRR) stock. FVRR stock has been struggling of late, but the core reason is somewhat ironic. It’s because the pandemic is fading. Source: by InvestorPlace The U.S. added just 194,000 jobs in September, while the lowest

Recently, I gave InvestorPlace readers my opinion on seven natural gas stocks to buy. At that time, I wasn’t paying much attention to penny stocks. If I had, I may have given Tellurian (NASDAQ:TELL) a closer look. The company is a play on liquefied natural gas (LNG), and it’s one of the up-and-coming players in this

Bionano Genomics (NASDAQ:BNGO) has turned into a bear of a meme play. But is there a chance for bullish DNA to be reproduced in BNGO stock? Source: Natali_ Mis/ShutterStock.com Let’s check in with what’s happening off and on the price chart of BNGO stock, then offer a risk-adjusted determination aligned with those findings. At a singular

A few months ago, I expressed some concerns about Lordstown Motors (NASDAQ:RIDE) stock and suffice to say, it was not well received. Source: Postmodern Studio / Shutterstock.com I could understand why. Even though the criticisms I received regarding my take on RIDE stock did not involve this admission, the reality is that no one likes

Greenidge Generation Holdings Inc. (NASDAQ:GREE) recently went public via a reverse merger on Sept. 15. Ever since then, GREE stock has lost more than 50% of its price. It currently trades around $25. Source: Shutterstock The reverse merger gave shareholders 115 shares of GREE stock for every 1,000 shares of Support.com stock they held. On

Buzz around The Metals Company (NASDAQ:TMC) stock will remain high in the coming weeks and months. TMC stock has been volatile since its Sept. 10 SPAC (Special Purpose Acquisition Company) merger with Sustainable Opportunities Acquisition.  Source: Manu Galdamez/ShutterStock.com The merger didn’t go exactly as planned, which has undoubtedly injected increased volatility into share prices. For

A very popular term in business is disruption, or causing a radical change through innovation. Hippo Holdings (NYSE:HIPO) is a digital homeowners insurance provider that went public in August. Potential HIPO stock investors wonder if this insurance provider will disrupt the insurance market. Source: TDKvisuals / Shutterstock.com It seems to me that HIPO stock lacks

Often attributed (though no one knows for sure) to Joseph Kennedy, a nevertheless oft-cited quote states, “If shoeshine boys are giving stock tips, then it’s time to get out of the market.” I don’t want to speak out of turn, but I’m having similar reservations about Sphere 3D (NASDAQ:ANY). Suddenly, it seems everyone is eyeballing

Recently, Novavax (NASDAQ:NVAX) fell fast. Closing at $207.31 per share on Sept. 30, the vaccine play opened at around $190 on Oct. 1. After that, NVAX stock quickly went into free fall, dropping as low as $154 per share. Source: Ascannio/Shutterstock.com The reason? Breaking news of Merck’s (NYSE:MRK) antiviral Covid-19 pill. Interim results suggest it

Have you been keeping an eye on the developments in the genetic editing space? We have. Source: Shutterstock And recently, CRISPR gene editing pioneer Feng Zhang achieved a breakthrough in CRISPR therapy cell-delivery. Instead of using the “default” Cas9 enzyme, Zhang used a sub-family of the Cas13 enzyme. One that’s just tiny enough to fit

After rising over $100 briefly this year, Cassava Sciences (NASDAQ:SAVA) stock is struggling to rebound. A long document written by the lawyer of a short-seller sent SAVA stock lower. The document challenged the accuracy of some of Cassava’s clinical results Source: Atthapon Raksthaput / Shutterstock.com Cassava has two major clinical studies underway. The top-line data

Shares in Greenidge Generation (NASDAQ:GREE) popped by 6.81% on Wednesday. That’s good news for investors, after GREE stock spent most of the past three weeks in a skid. In fact, GREE made it into Wednesday’s list of biggest pre-market stock movers. Before it began to lose steam, GREE stock gained as much as 17%. What was